IBJNews

Indiana companies that serve pharmaceutical industry grew in 2009

Back to TopCommentsE-mailPrintBookmark and Share
On The Beat Industry News In Brief

The state’s contract service providers, or CSPs, to the pharmaceutical industry, continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based life sciences trade group BioCrossroads.

Indiana is one of only a few states with a concentration of companies that provide specialized and sophisticated drug-development services such as contract research, contract manufacturing and logistical services.  

david-johnson-mug Johnson

Pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., have in recent years increasingly turned to CSPs as a way to reduce their own costs.

BioCrossroads has identified about 40 companies in the CSP sector here, employing more than 8,000 people.

“While pressure for outsourcing continues to increase, uncertainty over health care reform and tighter spending controls have created significant headwinds for a sector that had been growing revenues consistently in the double digits,” the BioCrossroads report said.

CSPs stand to get increasing business in areas such as the development of biomarkers to identify biological targets toward the development of more precise drug therapies.

Local successes last year include Indianapolis-based AIT Laboratories’ creation of a contract research division, AIT BioScience, and similar growth in manufacturing and research by Greenwood-based Elona Biotechnology.

“We believe the outlook for the biopharma-contract-service sector continues to be positive, particularly for Indiana’s pharmaceutical development and contract manufacturing companies,” said David Johnson, BioCrossroads’ CEO.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT